The navigation below allows you to jump to any table or figure within the SEER Cancer Statistics Review.

  1. First select the CSR Section, then a Table/Figure from that section.
  2. Use the Submit button to view the table or figure. You will have options to download a printer-friendly version (PDF) or the data table (CSV) as well.

To learn more about the Cancer Statistics Review and the statistics presented in this report, refer to the About the CSR (PDF, 528 KB) and Technical Notes (PDF, 794 KB) pages.

Download and Print: Download Printer-friendly PDF Download data

Table 22.21

Cancer of the Pancreas (Invasive)

United States Cancer Prevalence Estimates

Estimated United States Cancer Prevalence Counts a on January 1, 2017
By Race/Ethnicity, Sex and Years Since Diagnosis

Race/Ethnicity Sex Years Since Diagnosis Completee
0 to 5 >5 to 10 >10 to 15 >15 to 20 >20 to 25 <=25b >25d
All Races Both Sexes 57,729 10,952 4,618 1,929 1,010 76,239 2,731 78,969
Males 29,053 5,759 1,879 922 286 37,899 1,296 39,194
Females 28,677 5,193 2,739 1,007 724 38,340 1,435 39,775
White Both Sexes 47,797 8,888 3,811 1,535 804 62,836 2,220 65,055
Males 24,315 4,813 1,594 812 246 31,779 1,120 32,898
Females 23,482 4,075 2,218 724 558 31,057 1,100 32,157
Black Both Sexes 6,894 1,388 510 247 114 9,153 861 10,015
Males 3,194 619 177 70 9 4,069 404 4,473
Females 3,700 770 333 177 105 5,085 457 5,541
Asian/
Pacific
Islander		 Both Sexes 2,378 526 211 85 52 3,252 + +
Males 1,159 241 85 20 13 1,518 + +
Females 1,219 285 127 64 38 1,734 + +
Hispanic Both Sexes 4,702 805 408 181 108 6,204 + +
Males 2,021 361 133 71 5 2,591 + +
Females 2,681 445 274 110 103 3,613 + +

Estimated prevalence percent a on January 1, 2017, of the SEER population diagnosed in the previous 25 years
By Age at Prevalence, Race/Ethnicity and Sex

Race/Ethnicity Sex Age Specific (Crude) Age-Adjustedc
All Ages 0-9 10-19 20-29 30-39 40-49 50-59 60-69 70-79 80+ All Ages
All Races Both Sexes 0.0235 0.0000 0.0004 0.0011 0.0033 0.0103 0.0283 0.0650 0.1048 0.0977 0.0196
Males 0.0237 0.0001 0.0003 0.0004 0.0026 0.0087 0.0291 0.0723 0.1202 0.1108 0.0211
Females 0.0233 - 0.0005 0.0018 0.0040 0.0118 0.0275 0.0585 0.0919 0.0896 0.0184
White Both Sexes 0.0248 0.0000 0.0004 0.0012 0.0031 0.0097 0.0272 0.0643 0.1057 0.0980 0.0194
Males 0.0253 0.0001 0.0003 0.0004 0.0026 0.0082 0.0281 0.0722 0.1202 0.1132 0.0210
Females 0.0243 - 0.0004 0.0021 0.0037 0.0112 0.0263 0.0569 0.0933 0.0884 0.0181
Black Both Sexes 0.0201 - 0.0003 0.0006 0.0039 0.0130 0.0366 0.0770 0.1050 0.0895 0.0216
Males 0.0186 - 0.0003 0.0005 0.0027 0.0098 0.0382 0.0814 0.1264 0.0690 0.0219
Females 0.0215 - 0.0003 0.0007 0.0050 0.0159 0.0352 0.0735 0.0900 0.0997 0.0213
Asian/
Pacific
Islander		 Both Sexes 0.0156 0.0003 0.0009 0.0007 0.0039 0.0101 0.0224 0.0497 0.0814 0.0921 0.0164
Males 0.0152 0.0005 0.0005 0.0004 0.0028 0.0112 0.0218 0.0488 0.0987 0.1006 0.0176
Females 0.0160 - 0.0014 0.0010 0.0048 0.0091 0.0230 0.0505 0.0675 0.0865 0.0156
Hispanic Both Sexes 0.0107 - 0.0004 0.0014 0.0030 0.0086 0.0211 0.0516 0.0801 0.0840 0.0158
Males 0.0088 - 0.0005 0.0004 0.0014 0.0065 0.0181 0.0490 0.0875 0.0799 0.0149
Females 0.0126 - 0.0004 0.0025 0.0047 0.0108 0.0241 0.0540 0.0744 0.0866 0.0167

Footnotes:

a US 2017 cancer prevalence counts are based on 2017 cancer prevalence proportions from the SEER 13 Areas (excluding the Alaska Native Registry) and 1/1/2017 US population estimates based on the average of 2016 and 2017 population estimates from the US Bureau of the Census. Prevalence was calculated using the first invasive tumor for each cancer site diagnosed during the previous 25 years.

b Maximum limited-duration prevalence is 25 years for 1992-2017 data.

c Percentages are age-adjusted to the 2000 US Standard Population (19 age groups - Census P25-1130) by 5-year age groups.

d Cases diagnosed more than 25 years ago were estimated using the completeness index method (Capocaccia et. al. 1997, Merrill et. al. 2000).

e Complete prevalence is obtained by summing <=25 and >25.

- Statistic not shown. Statistic based on fewer than 5 cases estimated alive in SEER for the time interval.

+ Not available.

Page Navigation: << Previous Next >>

The information on this page is archived and provided for reference purposes only. Persons with disabilities having difficulty accessing information on this page may e-mail for assistance.